Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 4 4Phase 3 2Phase 2/3 2Phase 1/2 2Phase EARLY_PHASE1 1

Status

Unknown 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Endocrine 3NET 2Gastrointestinal 1

Conditions

Neuroendocrine Tumors 2Acromegaly 2Pituitary Neoplasms 1Neoplasms 1Gigantism 1Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × OTHER × lanreotide × Clear all
NCT05701241 2024-06-14

SAUNA

University Hospital, Antwerp

Phase 4 Recruiting
270 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

NCT01861717 2021-09-30

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

Saint John's Cancer Institute

Phase 4 Terminated
4 enrolled 5 charts
Endocrine

Acromegaly, Gigantism, Pituitary Neoplasms

NCT03083210 2019-05-20

Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET

Samsung Medical Center

Phase 4 Unknown
28 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT00627796 2008-03-03

ATG1line

Federico II University

Phase 4 Completed
27 enrolled

Acromegaly, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡